Active Ingredient History

NOW
  • Now
Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of chronic fatigue syndrome (CFS). There is some evidence it may improve some CFS symptoms.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No
ampligen | mismatched double-stranded rna | poly(inosinic acid) poly(cytidylic(12), uridylic)acid | poly i:poly c12u | poly(i)-poly(c12u) | poly(i).poly(c12,u) | (ri(n).r(c(12)u)n) | rintatolimod

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue